This is particularly true from the points of view of their molecular structural requirements for expression of biological activity, their biosynthesis and cataÂ bolism, their diverse range of biological activities, evidence for their specific recepÂ tors at the cell surface, the development of specific antagonists for use in receptor studies and for testing as potential anti-PAF drugs, and implications about their involvement in health and disease.
Books > Life Sciences.
Factor Lipid And Platelet-Activating Related Mediators.
The diversity of scientists now in PAF research is very apparent from the number of P AF publications appearing in a wide array of scientific journals, ranging from molecular biology to clinical medicine.
Although an enormous amount of information has been published about this interesting new type of phospholipid mediators, questions about their mechanism of action, regulatory controls, and the precise role and relative importance of P AF in specific diseases and physiological functions remain to be answered.
Following the identification of the chemical structure of P AF in 1979, much progress has been made in our understanding of these phospholipid mediÂ ators.
Publications related to PAF continue to increase at an amazingly rapid rate, with the pace reminiscent of the period following the discovery of prostaglandins.
Since the 1979 discovery, the PAF field has brought together scientists from a variety of different biomedical disciplines.
Platelet-activating factor (PAF) is the commonly used name for a group of potent biologically active, ether-linked phospholipids, the alkylacetylglycerophosphoÂ cholines
Books > Life Sciences
Platelet-Activating Factor And Related Lipid Mediators
Specifications of Platelet-Activating Factor And Related Lipid Mediators
|Category||メディア > 書籍|